GB1311015A - Pharmaceutical compositions and a process for the manufacture thereof - Google Patents

Pharmaceutical compositions and a process for the manufacture thereof

Info

Publication number
GB1311015A
GB1311015A GB598270*[A GB598270A GB1311015A GB 1311015 A GB1311015 A GB 1311015A GB 598270 A GB598270 A GB 598270A GB 1311015 A GB1311015 A GB 1311015A
Authority
GB
United Kingdom
Prior art keywords
garcinia acid
garcinia
manufacture
pharmaceutical compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB598270*[A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1311015A publication Critical patent/GB1311015A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1311015 Compositions comprising garcinia acid or derivatives thereof F HOFFMAN-LA ROCHE & CO AG 27 Oct 1970 [29 Oct 1969] 50982/70 Heading A5B A pharmaceutical composition comprises garcinia acid, a mono-, di- or tri-ester of garcinia acid, garcinia acid lactone, a diester of garcinia acid lactone, a non-toxic pharmaceutically acceptable basic salt of garcinia acid or garcinia acid lactone or esters thereof in admixture with a pharmaceutically acceptable carrier. The compositions may be made up in forms suitable for enteral or parenteral administration.
GB598270*[A 1969-10-29 1970-10-27 Pharmaceutical compositions and a process for the manufacture thereof Expired GB1311015A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87241369A 1969-10-29 1969-10-29

Publications (1)

Publication Number Publication Date
GB1311015A true GB1311015A (en) 1973-03-21

Family

ID=25359519

Family Applications (1)

Application Number Title Priority Date Filing Date
GB598270*[A Expired GB1311015A (en) 1969-10-29 1970-10-27 Pharmaceutical compositions and a process for the manufacture thereof

Country Status (9)

Country Link
BE (1) BE758122A (en)
CA (1) CA923425A (en)
DE (1) DE2052131A1 (en)
FR (1) FR2070174B1 (en)
GB (1) GB1311015A (en)
IE (1) IE34648B1 (en)
IL (1) IL35477A (en)
NL (1) NL7015348A (en)
ZA (1) ZA706931B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2106689A1 (en) * 1996-04-18 1997-11-01 Cabo Soler Jose New formulation based on hydroxycitric acid (salts and derivatives) and the cosmetic and pharmaceutical applications thereof by the percutaneous topical route.
WO2002102362A1 (en) * 2001-06-15 2002-12-27 Numico Research B.V. Dietetic preparation and use of an alpha-hydroxy carboxylic acid (citric acid for the treatment of obesity

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792180A (en) * 1971-12-02 1973-06-01 Hoffmann La Roche CITRIC ACID DERIVATIVES
FR2716374B1 (en) * 1994-02-18 1996-04-19 Sederma Sa New cosmetic or dermopharmaceutical compositions containing plant extracts.
IT1276253B1 (en) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR ALCANOIL L-CARNITINE FOR THE PREVENTION AND TREATMENT OF SOFT STATES

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2106689A1 (en) * 1996-04-18 1997-11-01 Cabo Soler Jose New formulation based on hydroxycitric acid (salts and derivatives) and the cosmetic and pharmaceutical applications thereof by the percutaneous topical route.
WO2002102362A1 (en) * 2001-06-15 2002-12-27 Numico Research B.V. Dietetic preparation and use of an alpha-hydroxy carboxylic acid (citric acid for the treatment of obesity

Also Published As

Publication number Publication date
NL7015348A (en) 1971-05-04
DE2052131A1 (en) 1971-05-06
FR2070174A1 (en) 1971-09-10
IL35477A (en) 1973-08-29
IL35477A0 (en) 1970-12-24
FR2070174B1 (en) 1974-02-22
BE758122A (en) 1971-04-28
ZA706931B (en) 1971-07-28
IE34648B1 (en) 1975-07-09
CA923425A (en) 1973-03-27
IE34648L (en) 1971-04-29

Similar Documents

Publication Publication Date Title
IL35400A0 (en) Furoyl and thenoylphenoxy acetic acid derivatives,their preparation and pharmaceutical compositions containing them
ES370058A1 (en) Antibiotic compositions
GB1311015A (en) Pharmaceutical compositions and a process for the manufacture thereof
ES419506A1 (en) {8 1-Oxo-2,3-hydrocarbylene-5-indanyloxy(or thio){9 alkanoic acids
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1525640A (en) Apovincaminol derivatives and a process for the preparation thereof
IL34872A0 (en) Aryloxy and arylthio acetic acid derivatives,their production and pharmaceutical compositions containing them
GB1270049A (en) New pharmaceutical product
AU461018B2 (en) Process for producing 4-hydroxymethyl-1-keto-1 2-dihydrophthalazine and acid salts thereof and pharmaceutical composition containing thesame
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
IL34255A0 (en) ((thenylidene amino)oxy)alkyl carboxylic acids,their esters and salts,their preparation and pharmaceutical compositions containing them
IL39885A0 (en) Substituted xanthone carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL38290A (en) Derivatives of thienyl-imidazolylfatty acids,their production and pharmaceutical compositions containing them
GB1327560A (en) Effervescent pharmaceutical preparations
IL37627A (en) 1,2,3,6-tetrahydro-4-pyridylmethyl esters of carboxylic acids and salts thereof,their preparation and pharmaceutical compositions containing them
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
IE33519B1 (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
IL35753A0 (en) Substituted anthranilic acids and derivatives thereof,their production and pharmaceutical compositions containing them
GB1331016A (en) Tripeptide and acid addition salts thereof and a process for the manufacture of same
GB1394397A (en) Chlorphenesin derivatives and method of making same
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1294538A (en) Pharmaceutical compositions
IL34769A (en) Alpha-(4-isobutyl-1-cyclohexen-1-yl)-alkanoic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
GB1312196A (en) Nicotinic acid derivatives and a process for the manufacture thereof
IL39888A (en) Heterocyclic-substituted xanthone carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee